Murari Mohun Pal

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Enalapril (EPL) is an angiotensin-converting enzyme inhibitor for the treatment of hypertension and chronic heart failure. Enalaprilat (EPLT) is an active metabolite that contributes to the overall activity of EPL. AIM To quantitate EPL along with its metabolite EPLT using LC-MS/MS, a bioanalytical method was developed and validated with(More)
  • 1